A vascular-targeting agent (VTA) or vascular disrupting agent (VDA) is a drug designed to damage the vasculature (blood vessels) of cancer tumors causing central necrosis.
VTAs can be small-molecule or ligand-based.
Small-molecule VTAs include:
- microtubule destabilizing drugs such as combretastatin A-4 disodium phosphate (CA4P), ZD6126, AVE8062, Oxi 4503
- vadimezan (ASA404)
Read more about Vascular-targeting Agent: Clinical Trials
Famous quotes containing the word agent:
“The average American is a good sport, plays by the rules. But this war is no game. And no secret agent is a hero or a good sport—that is, no living agent.”
—John Monks, Jr., U.S. screenwriter, Sy Bartlett, and Henry Hathaway. Robert Sharkey (James Cagney)